Top compounds associated with response to LYG2


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1 GDSC1000 pan-cancer AAC 0.084 0.01
mRNA phenformin GDSC1000 pan-cancer AAC 0.078 0.01
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.085 0.01
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.086 0.01
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.076 0.01
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.076 0.01
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.085 0.01
mRNA Imatinib GDSC1000 pan-cancer AAC -0.13 0.02
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.08 0.02
mRNA foretinib GDSC1000 pan-cancer AAC -0.076 0.02
Download CSV